Literature DB >> 19760612

The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx.

Mark E Zafereo1, Matthew M Hanasono, David I Rosenthal, Erich M Sturgis, Jan S Lewin, Diana B Roberts, Randal S Weber.   

Abstract

BACKGROUND: The objective of this study was to comprehensively review overall survival, functional outcomes, and prognostic factors in patients who underwent salvage surgery for locally recurrent squamous cell carcinoma of the oropharynx (SCCOP) after initial radiotherapy.
METHODS: The authors retrospectively reviewed 1681 consecutive patients who completed definitive therapy for primary SCCOP and identified 168 patients with locally recurrent SCCOP who underwent salvage surgery (41 patients), reirradiation or brachytherapy (18 patients), palliative chemotherapy (70 patients), or supportive care (39 patients).
RESULTS: Twenty-six of 39 patients (67%) developed a second recurrence after salvage surgery. The 3-year overall survival rate for patients who underwent salvage surgery or received reirradiation, palliative chemotherapy, or supportive care were 48.7%, 31.6%, 3.7%, and 5.1%, respectively. For patients who underwent salvage surgery, older age (P=.03), the absence of a disease-free interval (P<.01), and advanced recurrent tumor stage (P=.07) were associated with lower overall survival. Patients with recurrent neck disease (P=.01) and positive surgical margins (P=.04) had higher rates of recurrence after salvage surgery. Postoperative complications occurred in 19 patients (46%), and there were no perioperative deaths. Functionally, 71% of patients demonstrated>or=80% speech intelligibility, 68% were able to tolerate some oral intake, and 87% who required a tracheotomy subsequently were decannulated.
CONCLUSIONS: Age, disease-free interval, recurrent tumor stage, recurrent neck disease, and surgical margin status influenced overall survival or recurrence rate after salvage surgery for recurrent SCCOP. Although most patients had good functional outcomes, only a select group of patients with recurrent SCCOP achieved long-term survival after salvage surgery. Copyright (c) 2009 American Cancer Society.

Entities:  

Mesh:

Year:  2009        PMID: 19760612     DOI: 10.1002/cncr.24595

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  48 in total

1.  (18)F-FDG PET/CT to assess response and guide risk-stratified follow-up after chemoradiotherapy for oropharyngeal squamous cell carcinoma.

Authors:  Thomas Bird; Sally Barrington; Selvam Thavaraj; Jean-Pierre Jeannon; Andrew Lyons; Richard Oakley; Ricard Simo; Mary Lei; Teresa Guerrero Urbano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-28       Impact factor: 9.236

2.  When is reoperative surgery not indicated for recurrent head and neck squamous cell carcinoma?

Authors:  Juan P Rodrigo; Luiz P Kowalski; Carl E Silver; Remco de Bree; Alessandra Rinaldo; Ashok R Shaha; Primož Strojan; Mohamed N Elsheikh; Missak Haigentz; Alvaro Sanabria; H Hakan Coskun; Robert P Takes; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-11-26       Impact factor: 2.503

3.  Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma.

Authors:  Carole Fakhry; Qiang Zhang; Phuc Felix Nguyen-Tan; David Rosenthal; Adel El-Naggar; Adam S Garden; Denis Soulieres; Andy Trotti; Vilija Avizonis; John Andrew Ridge; Jonathan Harris; Quynh-Thu Le; Maura Gillison
Journal:  J Clin Oncol       Date:  2014-06-23       Impact factor: 44.544

4.  Outcomes of salvage surgery for the oropharynx and larynx: a contemporary experience in a UK Cancer Centre.

Authors:  Ashley Hay; Ricard Simo; Gillian Hall; Selvam Tharavai; Richard Oakley; Alastair Fry; Luke Cascarini; Mary Lei; Teresa Guerro-Urbano; Jean-Pierre Jeannon
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-01-21       Impact factor: 2.503

5.  Surface markers for guiding cylindrical diffuser fiber insertion in interstitial photodynamic therapy of head and neck cancer.

Authors:  Emily Oakley; David A Bellnier; Alan Hutson; Brian Wrazen; Hassan Arshad; Harry Quon; Gal Shafirstein
Journal:  Lasers Surg Med       Date:  2017-02-10       Impact factor: 4.025

Review 6.  AHNS Series: Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma.

Authors:  Cory D Fulcher; Missak Haigentz; Thomas J Ow
Journal:  Head Neck       Date:  2017-11-24       Impact factor: 3.147

7.  Salvage surgery for head and neck squamous cell carcinoma.

Authors:  Magis Mandapathil; Marion Roessler; Jochen A Werner; Carl E Silver; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-23       Impact factor: 2.503

8.  Predictors and Prevalence of Nodal Disease in Salvage Oropharyngectomy.

Authors:  M E Heft Neal; J Brennan; J C Brenner; A G Shuman; S B Chinn; C L Stucken; K M Malloy; J S Moyer; K A Casper; S A McLean; M E P Prince; C R Bradford; G T Wolf; D B Chepeha; A J Rosko; M E Spector
Journal:  Ann Surg Oncol       Date:  2019-09-19       Impact factor: 5.344

9.  PET/CT prior to salvage surgery in recurrent head and neck squamous cell carcinoma.

Authors:  A Nøhr; S B Gram; B Charabi; J F Tvedskov; I Wessel; J Friborg; K Håkansson; C von Buchwald; B M Fischer; Jacob H Rasmussen
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-11       Impact factor: 2.503

10.  Oropharyngeal squamous cell carcinoma in the veteran population: Association with traditional carcinogen exposure and poor clinical outcomes.

Authors:  Vlad C Sandulache; John Hamblin; Syeling Lai; Todd Pezzi; Heath D Skinner; Numan A Khan; Shayan M Dioun; Christine Hartman; Jennifer Kramer; Elizabeth Chiao; Xiaodong Zhou; Jose P Zevallos
Journal:  Head Neck       Date:  2015-07-04       Impact factor: 3.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.